63.82
前日終値:
$63.18
開ける:
$63.5
24時間の取引高:
11.81M
Relative Volume:
0.73
時価総額:
$94.85B
収益:
$20.08B
当期純損益:
$2.89B
株価収益率:
32.91
EPS:
1.9391
ネットキャッシュフロー:
$3.66B
1週間 パフォーマンス:
+3.17%
1か月 パフォーマンス:
-7.68%
6か月 パフォーマンス:
-33.69%
1年 パフォーマンス:
-32.30%
Boston Scientific Corp Stock (BSX) Company Profile
名前
Boston Scientific Corp
セクター
電話
508-683-4000
住所
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BSX
Boston Scientific Corp
|
63.82 | 91.83B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
ABT
Abbott Laboratories
|
101.05 | 174.29B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
345.88 | 129.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
88.12 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
EW
Edwards Lifesciences Corp
|
78.20 | 44.90B | 6.07B | 1.06B | 1.34B | 1.8063 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-30 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | ダウングレード | Erste Group | Buy → Hold |
| 2025-09-08 | アップグレード | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 開始されました | Leerink Partners | Outperform |
| 2025-04-16 | アップグレード | Needham | Hold → Buy |
| 2025-01-10 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-10-18 | ダウングレード | Needham | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2024-02-01 | アップグレード | Mizuho | Neutral → Buy |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-06-30 | 開始されました | CL King | Buy |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2022-12-22 | 開始されました | Mizuho | Neutral |
| 2022-12-20 | 再開されました | Citigroup | Buy |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-06 | 開始されました | Wolfe Research | Outperform |
| 2022-05-27 | アップグレード | Needham | Hold → Buy |
| 2022-04-13 | 再開されました | Truist | Buy |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-05-26 | ダウングレード | Needham | Buy → Hold |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-17 | 開始されました | Truist | Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
| 2020-04-22 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | アップグレード | Goldman | Neutral → Buy |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Buy |
| 2019-12-30 | 繰り返されました | Cowen | Outperform |
| 2019-12-19 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-09-05 | 再開されました | JP Morgan | Overweight |
| 2019-09-03 | 再開されました | Barclays | Overweight |
| 2019-05-13 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 開始されました | UBS | Buy |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-10-02 | 繰り返されました | Morgan Stanley | Overweight |
| 2018-09-07 | 繰り返されました | Needham | Strong Buy |
| 2018-09-04 | アップグレード | Jefferies | Hold → Buy |
| 2018-07-06 | 繰り返されました | Needham | Strong Buy |
| 2018-06-27 | 開始されました | Bernstein | Outperform |
| 2018-04-26 | 繰り返されました | Needham | Strong Buy |
すべてを表示
Boston Scientific Corp (BSX) 最新ニュース
Boston Scientific Corp. stock (US10117L1017): Is medtech innovation strong enough to unlock new upsi - AD HOC NEWS
BOSTON SCIENTIFIC CORPORATION (BSX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline - TMX Newsfile
Fund Update: 486,715 BOSTON SCIENTIFIC (BSX) shares added to Bank Pictet & Cie (Europe) AG portfolio - Quiver Quantitative
Faruqi & Faruqi, LLP Highlights Class Action Against Boston Scientific (BSX) and Upcoming Lead Plaintiff Deadline of May 4, 2026 - marketscreener.com
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Portnoy Law Firm Announces Class Action on Behalf of Boston Scientific Corporation Investors - GlobeNewswire
BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
Boston Scientific Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Barchart.com
Boston Scientific Corp. stock (US10117L1017): Is its medtech innovation edge strong enough to drive - AD HOC NEWS
BSX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - ChartMill
Why Boston Scientific's big dip could be a bigger opportunity - MSN
BSX Price History for Boston Scientific Corp Stock - Barchart.com
Boston Scientific (BSX) Receives FDA Clearance for Asurys Fluid Management System - Insider Monkey
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
ROSEN, A RANKED AND LEADING FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
BOSTON SCIENTIFIC CORPORATION (BSX) DEADLINE ALERT - GlobeNewswire
Boston Scientific Corp. stock rises Wednesday, still underperforms market - MarketWatch
Boston Scientific Faces Class Action Lawsuit from Shareholders - Intellectia AI
BSX INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Deals tracker: Orlando Health to acquire Alabama health system - Modern Healthcare
Boston Scientific Neuromodulation Lawsuit Claims Spinal Cord Stimulator Exacerbated Chronic Pain - AboutLawsuits.com
BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit - Barchart.com
Fidelity Advisor Global Capital Appreciation Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific (BSX) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
BOSTON SCIENTIFIC CORPORATION (BSX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline - TMX Newsfile
Leerink Reiterates Outperform on Boston Scientific (BSX) After CHAMPION-AF Readout - Insider Monkey
Boston Scientific stock hits 52-week low at 61.23 USD By Investing.com - Investing.com Australia
Boston Scientific stock hits 52-week low at 61.23 USD - Investing.com
Boston Scientific Corp (NYSE:BSX) Offers Affordable Growth for Value-Conscious Investors - ChartMill
Boston Scientific Corp. Stock Plummets to New 52-Week Low at USD 60.91 - Markets Mojo
Boston Scientific Corp. stock: Down 35% but analysts see rebound potential - AD HOC NEWS
Boston Scientific (BSX) Price Target Lowered by Evercore ISI Gro - GuruFocus
Boston Scientific closes buyout of Valencia Technologies - MedTech Dive
BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
Piper Sandler maintains Boston Scientific stock rating after device feedback - Investing.com
Piper Sandler maintains Boston Scientific stock rating after device feedback By Investing.com - Investing.com India
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Nike, Boston Scientific, And Sysco Are Among Top 10 Large Cap Losers Last Week (March 30-April 2): Are th - Benzinga
Boston Scientific Corporation (BSX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Boston Scientific Corp (MIL:1BSX) Bonds - GuruFocus
BSX Stockholders Have Opportunity to Lead Boston Scientific Corporation Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Boston Scientific Corporation (BSX) stock price, news, quote and history - Yahoo Finance Singapore
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Boston Scientific beats Q4 estimates, shares dip slightly - Investing.com
Boston Scientific Corp. Stock: Strong Growth in Medtech Amid Evolving Healthcare Demands - AD HOC NEWS
Boston Scientific completes acquisition of California bladder treatment company - Worcester Business Journal
BSX Shareholders Have Opportunity to Lead Boston Scientific Corporation Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
INVESTOR DEADLINE: Boston Scientific Corporation (BSX) - GlobeNewswire
RBC Capital reiterates Boston Scientific stock rating on growth outlook By Investing.com - Investing.com India
Boston Scientific Corp (BSX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):